DDIs in HIV Webinar: Real Cases, Expert Insights

José Moltó is clinical physician in the HIV Clinic of the Hospital Universitari Germans Trias i Pujol in Badalona, Spain. He obtained is MD from the University of Alicante in 1996, and completed his internal medicine training in the Hospital General Universitario de Elche (Alicante). Since his very early medicine studies, Dr. Moltó was interested in infectious diseases, particularly in HIV infection. He joined the HIV Clinic of the Hospital Universitari Germans Trias i Pujol in 2002, and he obtained his PhD degree from the Universitat Autònoma de Barcelona in 2008. He is committed with HIV research with special interest in clinical pharmacology of antiretroviral treatment, including population pharmacokinetics and drug-drug interactions.

Adrià Curran is a staff physician of the Infectious Diseases Department and the coordinator of the Anal Dysplasia Screening Unit of Vall d’Hebron University Hospital. He has carried out specific training on HPV anal dysplasia in HIV patients at the University of San Francisco (CA, USA) with Prof. Joel Palefsky. He is a member of the International Anal Neoplasia Society. He participates as a researcher in multiple international clinical trials and has published more than 100 articles in national and international journals and book chapters on various aspects of HIV infection, HPV and its treatment.

Catia Marzolini obtained a degree in Pharmacy followed by a PhD in Clinical Pharmacology at the University of Lausanne, Switzerland. She completed a post-doctoral fellowship within the Division of Clinical Pharmacology at Vanderbilt University, Nashville, USA.

Catia Marzolini is an Associate Professor at the University Hospital of Basel. Her main research interest is the pharmacology of antiretroviral drugs with a focus on drug-drug interactions, pharmacokinetics in special populations and prescribing issues in elderly people living with HIV. She has authored/co-authored more than 130 publications. Catia Marzolini is also the scientific lead of the University of Liverpool HIV and COVID-19 drug interactions websites. She serves on the European AIDS Clinical Society (EACS) guidelines committee where she co-chairs the drug-drug interaction section and is a member of the scientific board of the Swiss HIV Cohort Study.

Ezequiel Córdova MD, is an infectious diseases and clinical pharmacology specialist at the University of Buenos Aires, Argentina. He works as an infectious diseases specialist at the Infectious Diseases Unit of Hospital Cosme Argerich and as HIV clinical investigator in Fundación IDEAA, Buenos Aires, Argentina. He is Assistance Professor of Infectious Diseases at the University of Buenos Aires, Argentina. He is also associate editor for Actualizaciones en SIDA e Infectologia Journal (ASEI). He is member of the HIV and STI Comission of the Sociedad Argentina de Infectologia. Furthermore, he is the Coordinator of the “Pharmacology of Antiretroviral Drugs” chapter in the Argentinian Guidelines on antiretroviral treatment. His main research interests are TB/HIV coinfection, clinical pharmacology of antiretroviral treatment, drug-drug interactions and, antimicrobial resistance.